Abstract: Preterm infants present higher risk of non-optimal neurodevelopmental outcome. Fetal and postnatal growth, in particular head circumference (HC), is associated with neurodevelopmental outcome. Objectives: We aimed to calculate the relationship between HC at birth, HC delta Z-score (between birth and hospital discharge), and non-optimal neurodevelopmental outcome at 2 years of corrected age in preterm infants. Methods: Surviving infants born ≤34 weeks of gestation were included in the analysis. The relationship between the risk of being non-optimal at 2 years and both HC at birth and HC growth was assessed. The 2 Z-scores were considered first independently and then simultaneously to investigate their effect on the risk of non-optimality using a generalized additive model. Results: A total of 4,046 infants with both HC measures at birth and hospital discharge were included. Infants with small HC at birth (Z-score <-2 SD), or presenting suboptimal HC growth (dZ-score <-2 SD), are at higher risk of non-optimal neurodevelopmental outcome at 2 years (respectively OR 1.7 [95% CI 1.4-2] and OR 1.4 [95% CI 1.2-1.8]). Interestingly, patients cumulating small HC Z-score at birth (-2 SD) and presenting catch-down growth (HC dZ-score [-2 SD]) have a significantly increased risk for neurocognitive impairment (OR >2) while adjusting for gestational age, twin status, sex, and socioeconomic information. Conclusions: HC at birth and HC dZ-score between birth and hospital discharge are synergistically associated to neurodevelopmental outcome at 2 years of corrected age, in a population-based prospective cohort of preterm infants born ≤34 weeks of gestation.

1.
Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sánchez PJ, O'Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID 3rd, Watterberg KL, Saha S, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Neonatal outcome of extremely preterm infants from the NICHD neonatal research network. Pediatrics 2010;126:443-456.
2.
Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, Marlow N: Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012;345:e7961.
3.
Ancel PY, Livinec F, Larroque B, Marret S, Arnaud C, Pierrat V, Dehan M, N'Guyen S, Escande B, Burguet A, Thiriez G, Picaud JC, André M, Bréart G, Kaminski M; EPIPAGE Study Group: Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics 2006;117:828-835.
4.
Von Beckerath AK, Kollmann M, Rotky-Fast C, Karpf E, Lang U, Klaritsch P: Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. Am J Obstet Gynecol 2013;208:130.e1-e6.
5.
Kallankari H, Kaukola T, Olsén P, Ojaniemi M, Hallman M: Very preterm birth and foetal growth restriction are associated with specific cognitive deficits in children attending mainstream school. Acta Paediatr 2015;104:84-90.
6.
Morsing E, Asard M, Ley D, Stjernqvist K, Marsál K: Cognitive function after intrauterine growth restriction and very preterm birth. Pediatrics 2011;127:e874-e882.
7.
Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK: Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006;117:1253-1261.
8.
Leppänen M, Lapinleimu H, Lind A, Matomäki J, Lehtonen L, Haataja L, Rautava P; PIPARI Study Group: Antenatal and postnatal growth and 5-year cognitive outcome in very preterm infants. Pediatrics 2014;133:63-70.
9.
Ghods E, Kreissl A, Brandstetter S, Fuiko R, Widhalm K: Head circumference catch-up growth among preterm very low birth weight infants: effect on neurodevelopmental outcome. J Perinat Med 2011;39:579-586.
10.
Claas MJ, de Vries LS, Koopman C, Uniken Venema MM, Eijsermans MJ, Bruinse HW, Verrijn Stuart AA: Postnatal growth of preterm born children ≤750 g at birth. Early Hum Dev 2011;87:495-507.
11.
Neubauer V, Griesmaier E, Pehböck-Walser N, Pupp-Peglow U, Kiechl-Kohlendorfer U: Poor postnatal head growth in very preterm infants is associated with impaired neurodevelopment outcome. Acta Paediatr 2013;102:883-888.
12.
Concato J, Horwitz RI: Beyond randomised versus observational studies. Lancet 2004;363:1660-1661.
13.
Frondas-Chauty A, Simon L, Branger B, Gascoin G, Flamant C, Ancel PY, Darmaun D, Rozé JC: Early growth and neurodevelopmental outcome in very preterm infants: impact of gender. Arch Dis Child Fetal Neonatal Ed 2014;99:F366-F372.
14.
Amiel-Tison C: Update of the Amiel-Tison Neurologic assessment for the term neonate or at 40 weeks corrected age. Pediatr Neurol 2002;27:196-212.
15.
Josse D: Revised Brunet-Lezine Scale of Psychomotor Development of First Childhood. Paris, Etablissement d'Applications Psychotechniques, 1997.
16.
Squires J, Bricker D, Potter L: Revision of a parent-completed development screening tool: ages and stages questionnaires. J Pediatr Psychol 1997;22:313-328.
17.
Flamant C, Branger B, Nguyen The Tich S, de la Rochebrochard E, Savagner C, Berlie I, Rozé JC: Parent-completed developmental screening in premature children: a valid tool for follow-up programs. PLoS One 2011;6:e20004.
18.
Cole TJ: The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60.
19.
Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS: New intrauterine growth curves based on United States data. Pediatrics 2010;125:e214-e224.
20.
Rozé JC, Darmaun D, Boquien CY, Flamant C, Picaud JC, Savagner C, Claris O, Lapillonne A, Mitanchez D, Branger B, Simeoni U, Kaminski M, Ancel PY: The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT. BMJ Open 2012;2:e000834.
21.
WHO Child Growth Standards. Methods and development: length/height-for-age, weight-for-age weight-for-height and body mass index-for age. Geneva, World Health Organization. http://www.who.int/childgrowth/standards/Techinal_report.pdf.
22.
Parkinson CE, Scrivener R, Graves L, Bunton J, Harvey D: Behavioural differences of school-age children who were small-for-dates babies. Dev Med Child Neurol 1986;28:498-505.
23.
Hershkovitz R, Kingdom JC, Geary M, Rodeck CH: Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery doppler. Ultrasound Obstet Gynecol 2000;15:209-212.
24.
Lees CC, Marlow N, van Wassenaer-Leemhuis A, Arabin B, Bilardo CM, Brezinka C, Calvert S, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KT, Thilaganathan B, Todros T, Valcamonico A, Visser GH, Wolf H; TRUFFLE study group: 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015;385:2162-2172.
25.
Martin CR, Brown YF, Ehrenkranz RA, O'Shea TM, Allred EN, Belfort MB, McCormick MC, Leviton A; Extremely Low Gestational Age Newborns Study Investigators: Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics 2009;124:649-657.
26.
Cheong JL, Hunt RW, Anderson PJ, Howard K, Thompson DK, Wang HX, Bear MJ, Inder TE, Doyle LW: Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics 2008;121:e1534-e1540.
27.
Bartolomew J, Martin CR, Allred E, Chen ML, Ehrenkranz RA, Dammann O, Leviton A: Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN study. Neonatology 2013;104:298-304.
28.
Horbar JD, Ehrenkranz RA, Badger GJ, Edwards EM, Morrow KA, Soll RF, Buzas JS, Bertino E, Gagliardi L, Bellù R: Weight growth velocity and postnatal growth failure in infants 501 to 1500 grams: 2000-2013. Pediatrics 2015;136:e84-e92.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.